squibb - Search News

News

Bristol Myers Squibb Cuts Full-Year Adjusted View

Yahoo Finance · 4h

Should You Be Impressed By Bristol-Myers Squibb Company's (NYSE:BMY) ROE?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article

The Wall Street Journal on MSN · 11h

Bristol Myers Squibb Cuts Full-Year Adjusted View, but Raises Revenue Expectations

Bristol Myers Squibb trimmed its full-year adjusted earnings view as it reported lower second-quarter earnings due to a charge related to its BioNTech partnership.

Insider Monkey on MSN · 4h

Bristol-Myers Squibb Company (NYSE:BMY) Q2 2025 Earnings Call Transcript

Q2 2025 Earnings Call Transcript July 31, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is $1.46, expectations were $1.07. Operator: Good day, and welcome to the Bristol-Myers Squibb Second Quarter 2025 Earnings Conference Call.

PE Hub3h

Accel-KKR, Carlyle, Vistria target home care software; Bain Capital, Bristol Myers Squibb launch autoimmune biopharma biz

Rounding up five deals in the home healthcare sector, which has caught the attention of Accel-KKR, Berkshire Partners, ...

20h

2BMY : Bristol-Myers Squibb Unusual Options Activity For July 31

Out of all of the special options we uncovered, 26 are puts, for a total amount of $1,771,839, and 16 are calls, for a total amount of $839,064. Taking into account the Volume and Open Interest on ...

15don MSN

Major drugmakers offer big discount on blood thinner Eliquis

Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...

Devdiscourse1d

Bristol Myers Squibb Surprises with Strong Sales Yet Faces Investor Skepticism Over Future Growth

Bristol Myers Squibb reported unexpectedly strong second-quarter results, driven by legacy products like Eliquis, despite ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results